NCT05170945

Brief Summary

This investigation will utilize both a five-year retrospective analysis and a two-year prospective investigation. Variables including age; gender; presence of anticoagulation medication; hospital length of stay; total transfused red blood cell units; presence of heart failure, chronic kidney disease, or lung disease; history of diverticular disease; whether colonoscopy was performed; if therapeutic hemostasis was performed during colonoscopy; and information regarding prior colonoscopies in the past 10 years will be collected for analysis. A small number of early bowel preparation patients are expected in the retrospective study; therefore, a prospective study occurring over the next 12 months will be conducted. Patients agreeing to participate in the study would have a four-liter dose of PEG 3350 ordered, and the medication would be delivered within the first 24 hours of hospitalization. Radiographic studies including computed tomography angiography, tagged RBC scan, and angiography will not be obtained in the first 24 hours of hospital admission and be considered only if the patient has ongoing hematochezia at the completion of their bowel preparation. After completion of the 12-month investigative period (or earlier if sufficient sample size is obtained for clinical significance), data will be analyzed for dissemination consideration.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
415

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 22, 2020

Completed
1.3 years until next milestone

First Posted

Study publicly available on registry

December 28, 2021

Completed
1.2 years until next milestone

Study Start

First participant enrolled

March 28, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

March 31, 2023

Status Verified

March 1, 2023

Enrollment Period

1.1 years

First QC Date

September 22, 2020

Last Update Submit

March 30, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hospital length of stay

    Hospital length of stay in the early bowel preparation, late bowel preparation, and no bowel preparation groups.

    5 years of data will be collected

Secondary Outcomes (4)

  • Units of RBC transfused

    5 years of data will be collected

  • Colonoscopy details

    5 years of data will be collected

  • Therapeutic Hemostasis Invervention

    After discharge

  • Radiographic Studies

    5 years of data will be collected

Study Arms (2)

Retrospective Cohort

NO INTERVENTION

Colonoscopy was performed, either early bowel preparation, late bowel preparation or no bowel preparation patients.

Prospective Cohort

EXPERIMENTAL

Early bowel preparation for colonoscopy patients

Other: Early bowel preparation for colonoscopy

Interventions

Early (\<24 hours) bowel cleansing prior to colonoscopy.

Prospective Cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient admitted to Methodist Dallas Medical Center
  • Age greater than 18 years
  • Patient evaluated by gastroenterology consult service during admission
  • Hospitalization with diagnosis of "hematochezia", "acute gastrointestinal bleeding", "acute blood loss anemia", or "anemia"
  • Endorsed or witnessed episode of painless hematochezia
  • Patients exhibiting hemodynamic stability (heart rate \<110; systolic blood pressure \>90) after initial evaluation and resuscitation by admitting/emergency room physicians

You may not qualify if:

  • Age less than 18 years
  • Persistent hypotension despite initial intravenous fluid resuscitation or fever
  • Bowel preparation started 24 hours after initial presentation
  • Documented symptoms of dysphagia or odynophagia
  • Signs or symptoms suggestive of gastrointestinal obstruction (or ileus) on initial presentation (e.g., abdominal pain, nausea and/or vomiting)
  • Inability to complete bowel preparation
  • Personal history of inflammatory bowel disease or cirrhosis
  • History of immunosuppression (e.g., AIDS, immunosuppressive medication)
  • Personal history of colon cancer
  • Prior gastric bypass, small bowel, or colonic resection
  • Stool culture positive for tested organisms to include Clostridium difficile

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Methodist Dallas Medical Center

Dallas, Texas, 75203, United States

RECRUITING

MeSH Terms

Conditions

Diverticular Diseases

Interventions

Colonoscopy

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Prashant Kedia, MD

    The Methodist Hospital Research Institute

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 22, 2020

First Posted

December 28, 2021

Study Start

March 28, 2023

Primary Completion

May 1, 2024

Study Completion

May 1, 2024

Last Updated

March 31, 2023

Record last verified: 2023-03

Locations